Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care

Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care

Chair, Matthew D. Galsky, MD, discusses bladder cancer in this CME/MOC activity titled “The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/EQF865. CME/MOC credit will be available until April 19, 2023.